C. Van Den Berg

发表

Stress and IGF-I Differentially Control Cell Fate through Mammalian Target of Rapamycin (mTOR) and Retinoblastoma Protein (pRB)*

E. Knudsen, E. Koller, Amy M Sion, 2008, Journal of Biological Chemistry.

Serotonin Analogues as Inhibitors of Breast Cancer Cell Growth.

T. Kaoud, K. Dalby, C. Bartholomeusz, 2017, ACS medicinal chemistry letters.

Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects

D. Yee, Douglas Yee, Jennifer L. Gooch, 1999, Breast Cancer Research and Treatment.

Pharmacokinetics of hydroxyurea in nude mice

G. Wahl, D. V. Von Hoff, J. Kuhn, 1994, Anti-cancer drugs.

A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib

T. Kaoud, K. Dalby, N. Ebelt, 2017, Oncotarget.

ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion

T. Stracker, Blerta Xhemalçe, N. Ebelt, 2015, eLife.

UV-induced Apoptosis Is Mediated Independent of Caspase-9 in MCF-7 Cells

P. Marietta, H. A. Ferguson, C. Van Den Berg, 2003, Journal of Biological Chemistry.

c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade.

N. Ebelt, M. Cantrell, C. Van Den Berg, 2013, Genes & cancer.

Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.

S. Hilsenbeck, C. Osborne, D. Yee, 1997, European journal of cancer.

c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis.

C. L. Van den Berg, A. Nasrazadani, C. Van Den Berg, 2011, Genes & cancer.

c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression

C. Perou, A. Pfefferle, N. Ebelt, 2015, Oncotarget.

Extracellular Matrix Stiffening Induces a Malignant Phenotypic Transition in Breast Epithelial Cells

Laura J. Suggs, Courtney L. Davis, C. L. Davis, 2016, Cellular and Molecular Bioengineering.

American Association for Cancer Research April 20-24, 1996

C. Van Den Berg, 1996 .

DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.

M. Bittner, P. Meltzer, J. Trent, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration.

T. Kaoud, K. Dalby, C. L. Van den Berg, 2011, ACS chemical biology.

c-Jun N-terminal Kinase 2 (JNK2) Enhances Cell Migration through Epidermal Growth Factor Substrate 8 (EPS8)*

Ju-Seog Lee, S. Mitra, M. Cantrell, 2011, The Journal of Biological Chemistry.

Jnk2 Effects on Tumor Development, Genetic Instability and Replicative Stress in an Oncogene-Driven Mouse Mammary Tumor Model

L. Heasley, N. Ebelt, S. Mitra, 2010, PloS one.

Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes.

Amy Brock, Ning Jiang, Zhihua Liu, 2018, JCI insight.

Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice.

D. Yee, G. N. Cox, J. Kuhn, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Covalent JNK inhibitor, JNK-IN-8, suppresses tumor growth in triple-negative breast cancer by activating TFEB and TFE3 mediated lysosome biogenesis and autophagy.

Milad Soleimani, J. Kowalski, S. Eckhardt, 2022, Molecular cancer therapeutics.

PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.

Amy M Mingo-Sion, E. Koller, M. Reyland, 2005, Breast cancer research and treatment.

Use of hydroxyurea to alter drug resistance of human tumor cells.

D. V. Von Hoff, C. Van Den Berg, 1995, Cancer treatment and research.

Abstract 4109: Covalent JNK inhibitor, JNK-IN-8, suppresses tumor growth in triple-negative breast cancer in part by activating lysosome biogenesis and autophagy via TFEB and TFE3

Milad Soleimani, S. Eckhardt, K. Dalby, 2022, Cancer Research.

BCDIN3D RNA methyltransferase stimulates Aldolase C expression and glycolysis through let-7 microRNA in breast cancer cells

Nathan S. Abell, Blerta Xhemalçe, Marvin Mercado, 2021, Oncogene.

Stress and IGF-I Differentially Control Cell Fate through Mammalian Target of Rapamycin (mTOR) and Retinoblastoma Protein (pRB)*

E. Knudsen, E. Koller, Amy M Sion, 2008, Journal of Biological Chemistry.